Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol-Reference-Cited by-同舟云学术

Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol

Published:2021-11 Issue: Volume:124 Page:108325
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Anderson Christopher L.^ORCID,Evans Victoria,Gorham Laura,Liu Zhao,Johnson Cynthia R.,Carney Paul R.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Clinical Neurology,Neurology

Reference27 articles.

1. More than seizures: improving the lives of people with refractory epilepsy;Mula;Eur J Neurol,2015

2. The pathophysiology and treatment of autism;Posey;Curr Psychiatry Rep,2001

3. Pharmacotherapeutic management of autism;Posey;Expert Opin Pharmacother,2001

4. An update on pharmacotherapy of autism spectrum disorder in children and adolescents;Goel;Int Rev Psychiatry,2018

5. A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability;Efron;Br J Clin Pharmacol,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes and adaptive behavior in adult patients with Lennox–Gastaut syndrome;Epilepsia Open;2024-08-07

2. Mediating effects of sleep quality between clinical characteristics and quality of life in children with epilepsy: A cross-sectional study from Southwest China;Epilepsy & Behavior;2024-05

3. Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants;Paediatrics & Child Health;2024-04-05

4. Medical cannabis for children: Evidence and recommendations;Paediatrics & Child Health;2024-04-05

5. Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey;Epilepsy Research;2024-02